CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-12-12 | Kazam Joshua A Director | Purchase | +4,100 | $1.44 | $6K | 1,074,490 |
| 2008-12-11 | KASH PETER M Director | Purchase | +600 | $0.68 | $408 | 1,492,344 |
| 2008-12-11 | Kazam Joshua A Director | Purchase | +4,100 | $0.82 | $3K | 1,070,390 |
| 2008-12-11 | Evans Daron Chief Financial Officer | Purchase | +3,000 | $0.81 | $2K | 3,200 |
| 2008-12-11 | Evans Daron Chief Financial Officer | Purchase | +814 | $0.54 | $440 | 1,014 |
| 2008-12-11 | TANEN DAVID M Director | Purchase | +4,000 | $0.69 | $3K | 1,511,705 |
| 2008-12-11 | Strumph Peter M Chief Executive Officer | Purchase | +3,580 | $0.60 | $2K | 4,580 |
| 2008-04-15 | Lieu Hsiao VP, Clinical Research | Purchase | +100 | $4.60 | $460 | 100 |
| 2008-04-15 | SCHAFER GREGORY W Director | Purchase | +100 | $4.60 | $460 | 100 |
| 2008-04-14 | Evans Daron Chief Financial Officer | Purchase | +200 | $4.50 | $900 | 200 |
| 2008-04-14 | Evans Daron Chief Financial Officer | Purchase | +200 | $4.50 | $900 | 200 |
| 2008-04-14 | Evans Daron Chief Financial Officer | Purchase | +200 | $4.50 | $900 | 200 |
| 2008-04-14 | Evans Daron Chief Financial Officer | Purchase | +200 | $4.70 | $940 | 200 |
| 2008-04-14 | Strumph Peter M Chief Executive Officer | Purchase | +1,000 | $4.70 | $5K | 1,000 |
| 2008-04-14 | Strumph Peter M Chief Executive Officer | Purchase | +200 | $4.70 | $940 | 200 |
| 2008-04-14 | Strumph Peter M Chief Executive Officer | Purchase | +200 | $4.70 | $940 | 200 |
| 2008-03-10 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2008-03-04 | Evans Daron Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +76,528 | 76,528 | ||
| 2008-03-04 | Strumph Peter M Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +139,008 | 139,008 | ||
| 2008-01-25 | GRANADILLO PEDRO P Director | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 |
Page 30 of 31 · 605 trades